Boston Scientific reported that electrophysiology sales grew 172% in Q4 2024, driven by an uptake of its Farapulse pulsed field ablation (PFA) system. Revealing its Q4 and full-year results ...

Steven Mickelsen, the electrophysiologist who founded Farapulse before it was sold to Boston Scientific in 2021, is taking pulsed field ablation into new territory with the development of a device ...

Four of the 132 patients treated with Varipulse in the first two months of the U.S. launch had a form of stroke shortly after ...

In a wide manufacturing room with white walls and low ceilings, Boston Scientific employees combine components into finished ...

Applications are now being accepted for Future Docs, a leadership program of the Chattanooga-Hamilton County Medical Society ...

Why it matters: The first year of rolling out Farapulse in the US has been a smashing success, and we think Boston has made the most of its opportunity to upset what had been the long-standing ...

Boston Scientific Corp. emerged as the biggest winner by far. In its fourth quarter earnings call on Wednesday, the company quantified just how successful its Farapulse PFA system has been.